A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing Medicare drug price negotiations, a move that would fix one of the drug industry’s biggest complaints. The order applies to what the industry calls the Inflation Reduction Act’s “pill penalty,” where small molecule drugs—typically pills—face Medicare […]
Dominic Hughes Global health correspondent Getty Images Escherichia coli bacteria – also known as E. coli, the bug that causes food poisoning – is one of the bacteria that is showing greater resistance to front-line antibiotics More than three million children around the world are thought to have died in 2022 as a result of […]
Alarms sound as staff deal with medical emergencies in The Thistle’s using space Chris Clements BBC Disclosure The alarm is sounding in the UK’s first drug consumption room. A man in his 30s has overdosed in the “using space” – a room in the Glasgow facility where nurses supervise injections in eight booths. He had […]
Ben Godfrey BBC Midlands Today West Midlands Police Brian Pitts ran the operation with the help of his former partner, Katie Harlow, from a villa in Thailand A gang leader who co-ordinated a £4m fake Xanax drug-making operation in sheds and garages across the West Midlands has been jailed for eight years. Up to 11 […]
The Food and Drug Administration (FDA) approved the first generic versions of Vyvanse, a drug used to treat attention deficit/hyperactivity disorder (ADHD), a decision that comes amid a nationwide shortage of ADHD treatment drugs. The newly approved medication can treat both ADHD in patients six years and older and binge-eating disorder in adults, the FDA […]
Senate Republicans questioned the Biden administration’s plans to tackle prescription drug prices among other priorities during two hearings Wednesday featuring Health and Human Services Secretary Xavier Becerra. Biden’s budget proposals build off of the Inflation Reduction Act (IRA) passed last year, which allows Medicare to negotiate prices of certain drugs. The budget proposal would expand […]
Advocates Who Backed Approval Decry Cost Aducanumab had a rocky road to approval but had unwavering backing from the Alzheimer’s Association and at least one other organization, UsAgainstAlzheimer’s. The Alzheimer’s Association was particularly outspoken in its support, and, as reported by Medscape in March, was accused of potential conflict of interest by […]
June 9, 2021 — The FDA’s approval on Monday of a new drug to treat Alzheimer’s disease was met with both praise and criticism. As the first Alzheimer’s drug approved since 2003, advocates applaud the decision. Critics say the approval was based on inadequate proof that the drug works and balk at the price […]
In March 2019, late-stage international trials of aducanumab, involving about 3,000 patients, were halted when analysis showed the drug, given as a monthly infusion, was not better at slowing the deterioration of memory and thinking problems than a dummy drug. Source link
Aducanumab is the first new treatment for Alzheimer’s in nearly two decades, and has just been approved by regulators in the United States. This approval will pave the way for its use in the UK, where Aldo Ceresa was one of just a handful of patients in the country able to take part in a […]